Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001102624-14-001340
Filing Date
2014-08-14
Accepted
2014-08-14 16:23:51
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 AEOLUS PHARMACEUTICALS, INC. 10-Q aeolus10q.htm 10-Q 633725
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 14880
3 EXHIBIT 31.2 exh31_2.htm EX-31.2 14044
4 EXHIBIT 32.1 exh32_1.htm EX-32.1 9253
  Complete submission text file 0001102624-14-001340.txt   3915570

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aols-20140630.xml EX-101.INS 654452
6 XBRL TAXONOMY EXTENSION SCHEMA aols-20140630.xsd EX-101.SCH 30364
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aols-20140630_cal.xml EX-101.CAL 25028
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aols-20140630_def.xml EX-101.DEF 96710
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aols-20140630_lab.xml EX-101.LAB 225033
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aols-20140630_pre.xml EX-101.PRE 157118
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50481 | Film No.: 141043222
SIC: 2834 Pharmaceutical Preparations